Shanghai Shen Lian Biomedical Corp - Asset Resilience Ratio

Latest as of March 2026: 0.69%

Shanghai Shen Lian Biomedical Corp (688098) has an Asset Resilience Ratio of 0.69% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥10.52 Million

≈ $1.54 Million USD Cash + Short-term Investments

Total Assets

CN¥1.53 Billion

≈ $223.88 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how Shanghai Shen Lian Biomedical Corp's Asset Resilience Ratio has changed over time. Check 688098 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Shen Lian Biomedical Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 688098 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥10.52 Million	0.69%
Total Liquid Assets	CN¥10.52 Million	0.69%

Asset Resilience Insights

Limited Liquidity: Shanghai Shen Lian Biomedical Corp maintains only 0.69% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shanghai Shen Lian Biomedical Corp Industry Peers by Asset Resilience Ratio

Compare Shanghai Shen Lian Biomedical Corp's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Prostemics Co. Ltd KQ:203690	Biotechnology	0.31%
ORUM KQ:475830	Biotechnology	82.74%
TELIX Pharmaceuticals Ltd AU:TLX	Biotechnology	32.29%
TG Therapeutics Inc NASDAQ:TGTX	Biotechnology	4.72%
Green Cross Holdings Preference Shares KO:005257	Biotechnology	0.50%
Rocket Pharmaceuticals Inc NASDAQ:RCKT	Biotechnology	33.70%
NEWRON PHARMACEUT. EO-20 XETRA:NP5	Biotechnology	41.67%
Cybin Inc NEO:CYBN	Biotechnology	0.21%

Annual Asset Resilience Ratio for Shanghai Shen Lian Biomedical Corp (2020–2025)

The table below shows the annual Asset Resilience Ratio data for Shanghai Shen Lian Biomedical Corp.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	2.13%	CN¥32.82 Million ≈ $4.80 Million	CN¥1.54 Billion ≈ $225.70 Million	-0.69pp
2024-12-31	2.82%	CN¥43.81 Million ≈ $6.41 Million	CN¥1.55 Billion ≈ $227.42 Million	-7.37pp
2023-12-31	10.19%	CN¥162.38 Million ≈ $23.76 Million	CN¥1.59 Billion ≈ $233.25 Million	-8.82pp
2022-12-31	19.01%	CN¥305.12 Million ≈ $44.65 Million	CN¥1.61 Billion ≈ $234.87 Million	-7.52pp
2021-12-31	26.53%	CN¥424.08 Million ≈ $62.06 Million	CN¥1.60 Billion ≈ $233.91 Million	-4.67pp
2020-12-31	31.20%	CN¥472.45 Million ≈ $69.13 Million	CN¥1.51 Billion ≈ $221.61 Million	--

pp = percentage points

About Shanghai Shen Lian Biomedical Corp

SHG:688098 China Biotechnology

Market Cap

$505.36 Million

CN¥3.45 Billion CNY

Market Cap Rank

#12142 Global

#3501 in China

Share Price

CN¥8.41

Change (1 day)

+0.48%

52-Week Range

CN¥7.39 - CN¥15.40

All Time High

CN¥35.61